Our team provided and demonstrated a novel theory that RACGAP1 regulated by GABPA could promote proliferation and invasion in HCC via PI3K/AKT pathway both in vitro and vivo. The gene discussed is RACGAP1; the disease is hepatocellular carcinoma.